openPR Logo
Press release

Neurological Biomarkers Market 2017 - 2025 By Top Key Players: Quanterix Corporation, Qiagen N.V., Thermo Fisher Scientific Inc. ADx Neurosciences NV, Merck KGaA., Acobiom, Banyan Biomarkers, Olink AB INC., Bio-Rad Laboratories, EuroImmun AG

01-28-2019 03:08 PM CET | Health & Medicine

Press release from: Future Market Insights

Neurological Biomarkers Market 2017 - 2025 By Top Key Players:

Biomarkers have their own importance in the process of a therapeutic intervention. It is considered a crucial part of the drug discovery as well as the detection and cure of a disease. Neurological biomarkers is a new branch that is gaining traction in the global market. A new report by Future Market Insights depicts the progress of global neurological biomarkers market and the forecast for the upcoming years. This comprehensive research report projects the overview of global neurological biomarkers market, titled ‘Neurological Biomarkers Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2025)’. According to the report, global neurological biomarkers market is expected to showcase a significant growth in coming years with a CAGR of 5.1% during the forecast period, and reach a market value of over US$ 8,700 Mn by the end of 2025.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6626

Global Neurological Biomarkers Market: Snapshot

The neurological biomarkers are specific to the detection or analysis of molecular mechanism taking place in a person’s neurological disorder. Though the market’s scope is restricted to just the neurological segment of a human body, it holds a huge market share in the coming years. The growth is primarily driven by the increase of neurological disorders. There is a huge increase in the rate of population suffering from disorders like Alzheimer, Parkinson, Schizophrenia, Depression and Multiple Sclerosis. The prevalence of such diseases has also triggered the drug development practices. Many researches are solely dedicated to development of various drugs in the market which are based on the results of biomarkers. Thus, the global neurological biomarkers market is expected to proliferate in the coming years. The market includes highest application of neurological biomarkers for Alzheimer, which is expected to hold the highest market share of over US$ 2,100 Mn in the global neurological biomarkers market. However, new application areas like Schizophrenia and Spinal Muscular Atrophy are expected to witness more attractiveness in the global market, as both the segments are expected to lead with a growth at high rate.

The report also reveals the growth to be seen majorly in Asia Pacific during the forecast period. The region is expected to gain attractiveness in the coming years, as the neurological biomarkers market finds larger area of application and grow at a CAGR of 6.1% during the forecast period.

Request customized copy of report @ https://www.futuremarketinsights.com/customization-available/rep-gb-6626

Global Neurological Biomarkers Market: Upcoming Opportunities and Trends

Increasing prevalence of neurodegenerative disorders is expected to bolster the demand of neurological biomarkers in the global market. The growth is expected to introduce new trends in the market and help businesses capitalize on the opportunities coming their way. One of such trends is ELISA, which is a high sensitive method for detecting proteins in complex matrices such as urine, serum, plasma and saliva. It is considered as the best available method for quantification of proteins, and is also expected to gain traction in the coming years.

The major players that are behind introduction of such trends in the market and are also ruling the global neurological biomarkers market are Quanterix Corporation, Qiagen N.V., Thermo Fisher Scientific Inc. ADx Neurosciences NV, Merck KGaA., Acobiom, Banyan Biomarkers, Olink AB INC., Bio-Rad Laboratories, EuroImmun AG (Sub. PerkinElmer) etc. There are many more trends in the market like mass spectroscopy and integrative biology. The coming years will project clear picture of the trend that will stand out and lead as a significant driver of global neurological biomarkers market.

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market 2017 - 2025 By Top Key Players: Quanterix Corporation, Qiagen N.V., Thermo Fisher Scientific Inc. ADx Neurosciences NV, Merck KGaA., Acobiom, Banyan Biomarkers, Olink AB INC., Bio-Rad Laboratories, EuroImmun AG here

News-ID: 1538819 • Views: 237

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Fragmented by 2025
Global Biomarkers Market: Snapshot The global biomarkers market is witnessing a tremendous rise in its valuation, thanks to the increase in diagnostic applications of biomarkers. The augmenting investments for research and development activities in the pharma and biotech companies, rising number of CROs, and the low cost associated with the clinical trials in emerging economies are also boosting this market. Going forward, the high prevalence rate of cancer and novel initiatives for
Cancer Biomarkers Market: Regional Overview
Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Biomarkers Market : Analysis & Trends 2023
Global Biomarkers Market A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions
Global Vocal Biomarkers Market
The Global Vocal Biomarkers Market is estimated to be valued at US$ 6.4 million by 2017 and is projected to expand at an astounding CAGR of 65.7% from 2017 to 2028, as analyzed by Coherent Market Insights. Vocal biomarkers enabling early diagnosis and being a non-invasive procedure are analyzed to be major factor fueling uptake of this disruptive technology over the forecast period (2017–2028). Mental and physical conditions such as anxiety
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out